Doctors Note Logo

Published on: 5/22/2026

Understanding the Aspirin Desensitization Protocol: Specialist ENT Steps

Under specialist ENT care, aspirin desensitization is a structured multi-day protocol that gradually introduces increasing aspirin doses to patients with nasal polyps and aspirin-exacerbated respiratory disease to induce tolerance, reduce polyp recurrence, improve asthma control and lower steroid use while ensuring close monitoring for reactions.

There are several factors to consider from candidate selection, pre-protocol evaluation, step-wise dosing and maintenance regimens to benefits, risks and emergency precautions; see below to understand more.

answer background

Explanation

Understanding the Aspirin Desensitization Protocol: Specialist ENT Steps

Aspirin desensitization is a structured medical approach often used for patients with nasal polyps who also have aspirin-exacerbated respiratory disease (AERD). Under the care of an ENT specialist, this protocol can help reduce polyp recurrence, improve breathing, and lessen the need for systemic steroids. Below, you'll find a clear, step-by-step guide to what the process involves, who it's for, and what to expect. Always speak to a qualified ENT doctor about any serious or potentially life-threatening concerns.

What Is Aspirin Desensitization?

Aspirin desensitization is a controlled procedure that gradually introduces aspirin to the body in increasing doses. Over a period of days, the immune system becomes "tolerant," so that the standard daily dose of aspirin can be used safely. For patients with nasal polyps and AERD, this can:

  • Decrease nasal polyp size and symptoms
  • Reduce sinus infections
  • Lower reliance on steroids
  • Improve overall quality of life

The process must be performed in a specialist clinic with immediate access to emergency treatment.

Who Is a Candidate?

Not every patient with nasal polyps needs aspirin desensitization. Typical candidates:

  • Have confirmed AERD (asthma, nasal polyps, and sensitivity to aspirin/NSAIDs)
  • Experience frequent polyp regrowth despite surgery
  • Require multiple courses of systemic steroids per year
  • Are motivated to adhere to daily aspirin therapy

Contraindications include active gastrointestinal bleeding, significant kidney disease, or other bleeding risks. Your ENT will review your medical history, current medications, and overall health before recommending desensitization.

Pre-Desensitization Steps

Before starting the protocol, your ENT team will complete several preparatory steps:

  1. Comprehensive Evaluation

    • Nasal endoscopy or CT scan to assess polyp status
    • Spirometry (lung function test) to check baseline asthma control
    • Blood work to rule out contraindications
  2. Asthma Optimization

    • Adjust inhaled medications to ensure stable control
    • Confirm no recent asthma exacerbations
  3. Informed Consent

    • Discuss potential side effects (e.g., mild respiratory symptoms, flushing)
    • Review emergency procedures in case of severe reaction
  4. Medication Adjustments

    • Stop other NSAIDs at least 5 days in advance
    • Continue regular asthma and nasal spray medications

The Desensitization Protocol

Under close medical supervision, most ENT clinics follow a similar stepwise approach over 2–3 days:

Day 1

  • Start with a very low aspirin dose (e.g., 20–40 mg)
  • Observe for 1–2 hours
  • If tolerated, give the next higher dose (e.g., 75 mg)
  • Repeat observation and dosing until a cumulative dose of ~150–325 mg

Day 2 (if needed)

  • Continue from the last tolerated dose
  • Increase in small increments (e.g., 75–100 mg)
  • Target a cumulative dose of 325 mg by day's end

Day 3 (confirmation)

  • Administer a full 325 mg dose
  • Monitor for any late reactions

Key points:

  • Doses are given orally, usually under nurse supervision
  • Vital signs and lung function are checked before and after each dose
  • Emergency medications (bronchodilators, epinephrine) must be immediately available

Monitoring During Protocol

Close monitoring is essential to ensure safety:

  • Lung Function Tests: Before and after each dose to detect airway changes
  • Symptom Assessment: Watch for cough, wheezing, nasal congestion, or flushing
  • Vital Signs: Blood pressure, heart rate, and oxygen saturation

Minor symptoms are common and expected. If moderate or severe reactions occur (e.g., marked drop in lung function, severe wheezing), the dose is halted, and treatment is given. Most patients complete the protocol within 48–72 hours.

Post-Protocol Maintenance

Once desensitization is confirmed, maintaining a daily aspirin dose is crucial. Typical maintenance regimens:

  • 325 mg daily for the first 6 months
  • Some specialists reduce to 81–160 mg daily based on symptoms and tolerance

Patients should:

  • Take aspirin at the same time each day, with food to reduce stomach upset
  • Continue asthma and nasal spray medications as prescribed
  • Avoid other NSAIDs or painkillers that could interfere with tolerance

Regular follow-up visits (every 3–6 months) allow your ENT to:

  • Check nasal endoscopy for polyp recurrence
  • Assess asthma control
  • Adjust aspirin dose if needed

Benefits and Potential Risks

Understanding both sides can help you weigh whether this protocol is right for you.

Benefits

  • Fewer polyp surgeries and steroid courses
  • Improved nasal breathing and sense of smell
  • Better asthma control

Potential Risks

  • Gastrointestinal irritation or bleeding
  • Temporary worsening of asthma or nasal symptoms
  • Rare serious allergic reactions

Your specialist will take steps to minimize risks—such as prescribing a proton pump inhibitor to protect the stomach—and will have emergency treatments on hand during desensitization.

Lifestyle and Support Tips

  • Stay hydrated and eat small meals with aspirin to reduce GI discomfort.
  • Keep rescue inhalers and nose sprays nearby.
  • Keep a symptoms diary: track breathing, nasal congestion, and any side effects.
  • Join support groups or online forums for people with AERD.

When to Seek Immediate Help

Although mild reactions are part of the protocol, you should seek emergency care or call your doctor if you experience:

  • Severe shortness of breath or chest tightness
  • Blood in stool or vomit
  • Sudden, severe abdominal pain
  • Signs of anaphylaxis (hives, swelling of lips/tongue, difficulty swallowing)

For non-emergency symptoms that are concerning you, try Ubie's free Medically Approved AI Symptom Checker to help determine whether your symptoms require immediate attention.

Final Thoughts

Aspirin desensitization protocol for nasal polyps is a proven strategy to reduce polyp recurrence and improve respiratory health in AERD patients. It requires commitment, close medical supervision, and ongoing maintenance, but the benefits can be life-changing.

Always discuss any serious or life-threatening symptoms with your doctor or seek immediate emergency care. If you're experiencing new or unusual symptoms and aren't sure what to do next, Ubie's Medically Approved LLM Symptom Checker can provide personalized guidance in minutes. Remember, this information is educational and does not replace personalized medical advice. Discuss the risks, benefits, and logistics of aspirin desensitization with your ENT specialist to determine if it's the right path for you.

(References)

  • * White AA, Stevenson DD. Aspirin desensitization in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015 Feb;135(2):338-51. doi: 10.1016/j.jaci.2014.07.025. Epub 2014 Sep 11. PMID: 25220268.

  • * Laidlaw TM, Rank MA, Simon RA, White AA, Tichenor K, Stevenson DD, Lee RU, Cho E. Aspirin Desensitization in Chronic Rhinosinusitis With Nasal Polyps and Aspirin-Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2659-2665. doi: 10.1016/j.jaip.2021.03.045. Epub 2021 Mar 27. PMID: 33789178.

  • * Samaan J, Tieu DD, Benke JR, Hwang PH, Patel ZM. Aspirin-exacerbated respiratory disease in the otolaryngology clinic: current understanding and future directions. Am J Otolaryngol. 2022 May-Jun;43(3):103423. doi: 10.1016/j.ajoto.2022.03.003. Epub 2022 Mar 15. PMID: 35313936.

  • * Cho E, LaMattina KC, Lee RU, White AA, Stevenson DD, Laidlaw TM. Aspirin desensitization for recurrent nasal polyps and chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2171-2178.e1. doi: 10.1016/j.jaip.2020.01.006. Epub 2020 Feb 21. PMID: 32092576.

  • * Patel P, Thorp BD, Kuperstock JE, Soler ZM. Chronic Rhinosinusitis with Nasal Polyps and Aspirin-Exacerbated Respiratory Disease: An Evidence-Based Review. Laryngoscope. 2021 Dec;131(12):E3036-E3044. doi: 10.1002/lary.29074. Epub 2021 May 20. PMID: 33900667.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.